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Abstract
Background: This study investigated the influence of 2-months ingestion of an “immune” nutrient fortified
breakfast cereal on immune function and upper respiratory tract infection (URTI) in healthy children during the
winter season.
Methods: Subjects included 73 children (N = 42 males, N = 31 females) ranging in age from 7 to 13 years (mean
± SD age, 9.9 ± 1.7 years), and 65 completed all phases of the study. Subjects were randomized to one of three
groups–low, moderate, or high fortification–with breakfast cereals administered in double blinded fashion. The
“medium” fortified cereal contained B-complex vitamins, vitamins A and C, iron, zinc, and calcium, with the
addition of vitamin E and higher amounts of vitamins A and C, and zinc in the “high” group. Immune measures
included delayed-typed hypersensitivity, global IgG antibody response over four weeks to pneumococcal
vaccination, salivary IgA concentration, natural killer cell activity, and granulocyte phagocytosis and oxidative burst
activity. Subjects under parental supervision filled in a daily log using URTI symptoms codes.
Results: Subjects ingested 3337 ± 851 g cereal during the 2-month study, which represented 14% of total diet
energy intake and 20-85% of selected vitamins and minerals. Despite significant increases in nutrient intake, URTI
rates and pre- to- post-study changes in all immune function measures did not differ between groups.
Conclusions: Data from this study indicate that ingestion of breakfast cereal fortified with a micronutrient blend
for two winter months by healthy, growing children does not significantly influence biomarkers for immune
function or URTI rates.
Background
Nutrients are involved in the immune response to
pathogens, facilitating cell division and the production
of specific antibodies and cytokines, and in providing
metabolic support for skin and mucosa physical barriers
[1]. Enzymes in immune cells require the presence of
micronutrients, and critical roles have been defined for
nearly all nutrients, including zinc, iron, copper, sele-
nium, and vitamins A, C, E, D, and B6 [2,3]. One of the
earliest interactions between nutrition, immunity, and
infection was established in malnourished children [4,5].
Nutritional deficiencies and immune dysfunction, with
improvements measured following immunonutrition
support, have been linked in several other groups
including the frail elderly, patients experiencing surgery,
illness, and trauma, and human immunodeficiency virus
(HIV) infected individuals [6-13].
Less clear is the immune-related benefit of nutrient
supplementation among healthy children and adults
with no overt signs of immune system deficiencies.
Among free-living adults, a wide variance in self-selected
diet intake is compatible with normal immune function
[14-16]. High compared to low self-selected intake of
vitamins through diet or supplements by adults is not
associated with altered risk of pneumonia [17,18].
Although data are limited, mixed or single micronutri-
ent supplementation among healthy, community-dwell-
ing adults is largely ineffective in altering innate or
adaptive immune function, or in lowering respiratory
infection rates [19-24].
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tion in young, malnourished or diseased children in
developing countries reduces respiratory infection mor-
bidity and helps counter impaired immunity [25-31].
The influence of mixed micronutrient supplementation
on immune function and incidence of upper respiratory
tract infections (URTI) in healthy children is largely
unstudied [32]. Children suffer from a high rate of
URTI, and the physiologic stress of rapid growth and
suboptimal dietary quality may provide room for
immune benefit through micronutrient supplementation
[3]. We hypothesized that school-aged children would
experience improvements in innate and adaptive
immune function and a reduction in URTI during two
winter months of supplementation with a mixture of
immune-related micronutrients administered through a
fortified breakfast cereal.
Methods
Subjects and research design
Seventy-three children (42 boys and 31 girls) ranging in
age from 7 to 13 years, and in body mass index from 13
to 36 kg/m
2, were recruited from local elementary
schools and home school programs. Inducements
included subject stipends and free results of fitness,
body composition, and immune function tests. This
study was conducted according to the guidelines laid
down in the Declaration of Helsinki and all procedures
involving human subjects/patients were approved by the
university’s Institutional Review Board for Human Stu-
dies. Written informed consent was obtained from all
subjects and a parent. A parent for each child attended
all orientation and test sessions, and assumed responsi-
bility for home feeding, dietary recording, health logs,
and transportation of their children to the laboratory.
Triceps and subscapular skinfolds were measured in
each child and summed using the procedures of Loh-
man et al. [33]. The skinfolds were measured by one
trained technician using a Lange skinfold caliper (Cam-
bridge Scientific Industries, Cambridge, MA).
Subjects were tested for immune function pre-study,
and then again two months later following a regimen of
micronutrient supplementation through ingestion of a
fortified breakfast cereal. The subjects used a daily
health log to record symptoms of sickness using number
codes. A pneumococcal vaccine was administered half-
way through the study, with the antibody response mea-
sured one month later (post-study).
Supplementation regimen
Subjects were randomized to one of three groups–low,
medium, or high fortification–with breakfast cereals
administered in double blinded fashion. Extruded,
expanded, puffed corn cereal products with selected
micronutrient blends were supplied by General Mills in
coded boxes (Minneapolis, MN). For all groups, each
100 g cereal provided 400 kilocalories, 6.7 g protein,
86.7 g carbohydrate, 1.7 g fat, 3.3 g dietary fiber, 133 mg
potassium, and 900 mg sodium. The “low” fortification
group received the following nutrients per 100 g cereal:
0.8 mg vitamin C, 133 mg calcium, and 0.6 mg iron.
The calcium provided in the low fortification cereal
e n s u r e dt h a ts u b j e c t sr e c e i v e dp a r t i a ls u p p o r tf o rg r o w -
ing bones. The “medium” fortification group received
the following nutrients per 100 g cereal: 1.3 mg thiamin,
1.4 mg riboflavin, 16.7 mg niacin, 1.7 mg vitamin B6,
5.0 μg vitamin B12, 20.0 mg vitamin C, 1,667 IU vitamin
A, 667 μg folate, 500 mg calcium, 27.0 mg iron, and
12.5 mg zinc. The “high” fortification group received the
same amount of nutrients as the “medium” group, with
higher amounts of the following nutrients per 100 g cer-
eal: 100 mg vitamin C, 8,333 IU vitamin A, 18.5 mg
vitamin E (a-tocopherol equivalents), and 25.0 mg zinc.
If 100 g cereal were consumed per day, the “high” forti-
fication cereal would have provided approximately 50%
of the U.S. Daily Value.
Subjects were given two coded boxes for each week of
the study, with instructions to consume two to three
measured cups (~50-70 g) per day (anytime of the day)
for two months. Intake was recorded in daily logs by the
subjects/parents, and all unconsumed cereal was
returned to investigators for weighing to determine
actual intake. To remain in the study, subjects had to
consume a minimum of 1,700 g cereal during the study
period. Subjects (with parental supervision) were
instructed to avoid all other forms of nutrient supple-
ments during the 2-month study.
Diet intake was estimated through 3-day food records
pre-study, and then again after one and two months.
The study dietitian provided detailed instructions using
food models and volume measuring supplies to subjects
and parents regarding methods for recording volume
and portion size in the 3-day food records, and then
entered the information into a computerized dietary
analysis system, Food Processor Plus (ESHA Research,
Salem, Oregon).
Blood and saliva sample collection
Children and parents reported to the testing facility
between the hours of 7:30-9:30 am having avoided
energy intake for the previous 9 h. A 4-min timed saliva
sample was first collected followed by a blood sample
drawn by trained pediatric phlebotomists. A delayed-
type hypersensitivity (DTH) skin test was administered
using the Mantoux method with three antigens (Can-
dida albicans, mumps antigen, and tetanus toxoid).
Each subject reported back to the testing lab two days
later for a 48-h measure of skin induration. One month
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a pneumococcal vaccination by medical personnel. At
the end of the two-month period, saliva and blood sam-
ples were again collected, and the DTH skin test
readministered.
Immune assay measurements
All blood samples were obtained from an antecubital
vein from the children while in the supine position after
having rested for more than 15 min. Routine complete
blood counts were performed by a clinical hematology
laboratory (Lab Corp, Burlington, NC), and provided
leukocyte subset counts.
Lymphocyte subsets
The proportions of T cells (CD3
+), B cells (CD19
+), and
NK cells (CD3
-CD16
+CD56
+) were determined in whole
blood preparations and absolute numbers calculated
using CBC data to allow group comparisons on blood
concentrations of cells. Lymphocyte phenotyping was
accomplished by two-color fluorescent labeling of cell
surface antigens with mouse anti-human monoclonal
antibodies conjugated to fluoresceinisothiocyanate
(FITC) and phycoerythrin (PE) using Simultest mono-
clonal antibodies and isotype controls (Becton Dickin-
son, San Jose, CA). For immunophenotyping, 50 μl
aliquots of heparinized whole blood from each sample
were added to five wells of a 96 well plate. Five μg
(diluted in 50 μl RPMI ) of each antibody or isotype
control were added to appropriate wells for 20 min on
ice in the dark with orbital shaking (170 rpm). The cell
suspension was then lysed using 200 μlF A C S l y s es o l u -
tion (Becton Dickinson) for 10 min in the dark on ice
with shaking. Plates were then centrifuged for five min
(Beckman GS-R6 Centrifuge) at 1500 × g. Samples were
kept at 4°C in the dark until analyzed by flow cytometry
(FacsCalibur, Becton Dickinson, San Jose, CA)
Natural killer cell activity (NKCA)
NKCA was assessed using the chromium release assay
[34,35]. Peripheral blood mononuclear cells were iso-
lated from heparinized blood by density gradient centri-
fugation with Ficoll and sodium diatrivoate (American
Red Cross, Washington D.C.).
51Chromium labeled
K562 target cells were then added (1 × 10
4) to each of
the wells containing effector cells to yield 40:1 and 20:1
effector to target (E:T) ratios. The assay was performed
in triplicate in “V” bottom microtiter plates (Costar,
Cambridge, MA). The microtiter plates were then incu-
bated for 4 h at 37°C in a 5% C02 (in air) incubator. At
the end of the incubation, the plates were centrifuged
for 5 min at 1500 rpm, the supernatants harvested onto
Skatron harvesting frames (Skatron, Sterling, VA), and
the level of radioactivity measured in a Packard Tri
Carb Liquid Scintillation Analyzer model 2500 TR series
(Packard Instruments Company, Meriden, CT). Total
release of
51Cr was determined by counting an equal ali-
quot of resuspended cells in 100 μlo f1 %t r i t o n - X
(Sigma, St. Louis, MO). Spontaneous release was deter-
mined by counting the radioactivity in the supernatant
of labeled target cells cultured in medium alone. The
percent lysis was calculated using the mean counts per
min (cpm) of triplicate values for each E:T ratio and the
following formula:
%lysis =
cpm (test) - cpm (spontaneous)
cpm (total) -c p m(spontaneous)
× 100
Granulocyte phagocytosis and oxidative burst activity
The phagocytosis assay utilized a FITC-labeled bacteria
(Staphylococcus aureus; Molecular Probes, Eugene, OR)
to quantify the degree of phagocytosis by granulocytes, as
described in a previous publication [34]. Briefly, to deter-
mine the extent of oxidative burst exhibited by granulo-
cytes, we employed 2’,7’-dichlorodihydrofluorescein
diacetate (DCF-DA; Molecular Probes), a non-fluorescent
molecule which is oxidized to green fluorescent dichloro-
fluorescein (DCF) as oxygen radicals are generated in the
oxidative burst to kill unlabeled Staphylococcus aureus.
The white blood cell count was acquired using the Bec-
ton Dickinson Unopet manual counting protocol. Using
two-color flow cytometric immunophenotying (CD45-
FITC/CD13,14-PE), the granulocyte percentage was
determined. Bioparticle reagents of unlabeled and labeled
Staphylococcus aureus were suspended into PBS at a
working concentration of 3 × 10
5 bioparticles/μl. After
determining the number of phagocytic cells in 100 μlo f
whole blood, and adding 15 FITC-labeled bacteria per
cell, the mean channel fluorescence (FITC) was analyzed
to determine the degree of engulfed bacteria (non-phago-
cytized bacteria were quenched with ethidium bromide;
final concentration of 200 μM). To determine the oxida-
tive burst activities, either DCF-DA (final concentration,
100 μM) (basal activity level), or DCF-DA and unlabeled
bacteria (stimulated activity level) were added to 100 μl
whole blood. After incubating the samples for 60 min
(37°C) in the dark, lysing the RBC, centrifuging, and
resuspending the pellets, the samples (10,000 phagocytes)
were acquired on the flow cytometer.
Salivary IgA
Unstimulated saliva was collected for four min into 5
mL plastic, sterilized vials. Participants were urged to
pass as much saliva as possible into the vials during the
4-min timed session. Saliva volume was measured to the
nearest 0.1 mL, and then frozen at -80°C until analysis.
Salivary IgA was measured by enzyme linked immuno-
sorbent assay (34). The data were expressed as concen-
tration of sIgA (μg
. mL
-1), concentration of sIgA
relative to total protein concentration (μg
. mg
-1), and
salivary immunoglobulin secretion rate (μg
. min
-1).
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The DTH skin response was assessed with use of three
antigens, Candida albicans, mumps antigen, and tetanus
toxoid (diluted 5:1), by the Mantoux method with nee-
dle and syringe (Allermed Laboratories, Inc., San Diego,
CA; Aventis Pasteur, Swiftwater, PA). The volar surfaces
of the left and right arms were cleansed and labeled
(mumps antigen and tetanus toxoid on the left arm,
Candida albicans on the right). At each site, a needle
was inserted into the skin at a 45 degree angle to a
depth of <0.2 mm, and 0.1 mL of antigen injected until
a 5 mm pea-sized bleb was produced. After 48 h, sub-
jects returned to the lab, and the DTH response at each
test site measured. The extent of the induration
response was palpated at the reaction area (manifested
as firmness and redness), outlined with a black-ink ball-
point pen, and then removed with scotch tape prior to
mounting on the skin test record form. The tape
impress for each induration was measured across two
diameters and averaged.
Pneumoccocal vaccination and IgG antibody response
Plasma samples were collected one month before and
one month after the children were administered a single
0.5 mL dose of PNEUMOVAX 23 intramuscularly (del-
t o i dm u s c l e )( M e r c k&C o . ,I n c . ,W e s tP o i n t ,P A ) .T h e
plasma samples were assayed for specific IgG antibodies
against Pneumococcal Capsular Polysaccharide (PCP)
(BINDAZYME™ Anti-PCP IgG Enzyme Immunoassay
Kit, MK012, The Binding Site LTD, Birmingham, Eng-
land). The measuring range of the assay for anti-PCP
IgG antibodies levels is 3.3-270 mg/l, with an intra-assay
precision of 3.1-5.9% CV and an analytical sensitivity of
0.62 mg/l.
Upper respiratory tract infection log
Subjects with parental assistance recorded URTI symp-
toms on a daily basis in a log using numbered codes.
The following health problems were recorded, in accor-
dance with previous investigations by our research team
[36]: 1) No health problems; 2) Cold symptoms (runny,
stuffy nose, sore throat, coughing, sneezing, colored dis-
charge); 3) Flu symptoms (fever, headache, general aches
and pains, fatigue and weakness, chest discomfort,
cough); 4) Nausea, vomiting, and/or diarrhea; 5. Muscle,
joint, or bone problems/injury; 6) Other health pro-
blems. An URTI episode was recorded if cold (#2 item)
or flu (#3) symptoms persisted for two days or longer.
The primary outcome reported in this study is the total
days with URTI symptoms. URTI severity and duration
per episode were not monitored or calculated in this
study.
Statistical methods
Data are reported as mean ± SD, and were analyzed
using SPSS 11.5 (SPSS Inc., Chicago, IL). The dietary
intake data were analyzed using 3 (groups) × 3 (times of
measurement) repeated measures ANOVA, with
immune data analyzed using a 3 × 2 repeated measures
MANOVA. When Box’s M suggested a violation of
homoscedasticity assumption in MANOVA, Pillais trace
statistic was used as the test statistic because it has been
shown to be robust against departures from covariance
equality. If the group × time interaction P value was ≤
0.05, a change variable was calculated and compared
between groups using Bonferroni adjusted Student’st -
tests. URTI data from the daily logs were combined into
group averages and the total number of sick days
recorded was compared between groups using oneway
ANOVA. Chi-square analysis was used to compare the
number of children across groups who reported at least
one URTI episode during the study period. Power analy-
sis was performed after the study was conducted using
the fpower macro in SAS (SAS Institute, Inc., Cary,
NC), and revealed that 41 to 142 subjects would be
needed (depending on the immune measure) to achieve
80% power. The power analysis is a conservative esti-
mate and was conducted a posteriori because data on
children for all of the immune measures used in this
s t u d yw e r en o ta v a i l a b l ep r i o rt ot h es t u d y .W e
acknowledge that the sample size is considered marginal
for this study, but subjects were well randomized, and
the results are in accordance with what we and other
have observed in adults.
Results
Seventy-three children (55% male, 45% female) started
the study, and 65 adhered to all aspects of the study
design and were included in the statistical analysis.
Groups did not differ significantly in subject characteris-
tics, and data are provided in Table 1 for all 65 subjects
completing the study. Subjects consumed an average of
3337 ± 851 g cereal during the two month study, and
this quantity did not vary significantly between groups.
Nutrient intake (combining self-selected diet and forti-
fied cereal) is summarized in Table 2 for each group. In
comparison to the low group, intake of B-complex vita-
mins, vitamin A, zinc, and iron was elevated in the med-
ium and high groups at 1- and 2-months, with vitamins
Table 1 Subject characteristics (N = 65), mean ± SD*
Variable Mean ± SD Range
Age (yrs) 9.8 ± 1.8 7-13
Body mass (kg) 40.7 ± 14.4 23.5-90.3
Stature (m) 1.46 ± 0.11 1.22-1.65
Body mass index (kg/m
2) 18.9 ± 4.8 13.4-35.9
Sum of 2 skinfolds (mm) 29.5 ± 17.9 9.5-83.8
* For subjects adhering to all aspects of the 2-month research project. Data
represent mean values of pre- and post-study measures.
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two-months ingestion of cereal product (low-, medium, and high fortification) in children
Variable Pre-study 1-month 2-months Interaction p-value
Energy (kcal)
Low (N = 23) 2313 ± 785 2164 ± 764 2096 ± 851 0.890
Medium (N = 22) 2246 ± 632 2096 ± 535 2084 ± 564
High (N = 19) 2132 ± 429 2178 ± 577 1952 ± 547
Vit E (a-TE, mg)
Low 4.30 ± 2.36 4.41 ± 3.72 4.24 ± 2.45 <0.001
Medium 4.20 ± 1.84 3.24 ± 1.97 3.63 ± 1.81
High 4.28 ± 1.93 13.3 ± 5.08* 13.6 ± 5.11*
Vit C (mg)
Low 82.3 ± 77.4 68.2 ± 64.6 92.9 ± 89.1 0.002
Medium 79.2 ± 45.8 95.7 ± 86.0 104 ± 95.3
High 90.2 ± 64.1 178 ± 75.2* 176 ± 58.5
Vit A (RE)
Low 265 ± 112 239 ± 128 237 ± 144 <0.001
Medium 289 ± 126 572 ± 147* 583 ± 114*
High 266 ± 117 1727 ± 431* 1657 ± 589*
Thiamin (mg)
Low 1.62 ± 0.73 1.06 ± 0.58 1.15 ± 0.50 <0.001
Medium 1.57 ± 0.66 1.74 ± 0.55* 1.64 ± 0.47*
High 1.48 ± 0.35 1.87 ± 0.85* 1.67 ± 0.51*
Riboflavin (mg)
Low 1.90 ± 0.87 1.47 ± 0.78 1.54 ± 0.72 0.002
Medium 1.90 ± 0.87 2.23 ± 0.80* 2.24 ± 0.77*
High 1.73 ± 0.63 2.23 ± 0.50* 2.14 ± 0.64*
Niacin (mg)
Low 19.4 ± 8.4 15.1 ± 9.3 15.4 ± 8.0 0.011
Medium 19.9 ± 9.3 21.5 ± 7.1* 21.4 ± 6.4*
High 17.9 ± 6.4 23.9 ± 11.8* 21.2 ± 7.8*
Vit B6 (mg)
Low 1.36 ± 0.57 1.06 ± 0.51 1.16 ± 0.62 <0.001
Medium 1.45 ± 0.72 1.82 ± 0.64* 1.88 ± 0.62*
High 1.23 ± 0.48 1.98 ± 0.71* 1.81 ± 0.64*
Vit B12 (mcg)
Low 3.34 ± 1.82 3.30 ± 2.32 2.74 ± 1.43 0.002
Medium 3.80 ± 2.07 5.40 ± 1.79* 5.02 ± 1.70*
High 3.22 ± 1.63 5.37 ± 1.71* 4.97 ± 1.82*
Folate (mcg)
Low 288 ± 143 156 ± 79 185 ± 97 <0.001
Medium 265 ± 121 548 ± 174* 499 ± 167*
High 249 ± 89 513 ± 177* 509 ± 151*
Iron (mg)
Low 16.2 ± 6.6 10.4 ± 3.8 10.5 ± 3.2 <0.001
Medium 16.1 ± 6.8 26.6 ± 6.6* 24.4 ± 7.2*
High 14.0 ± 4.2 25.3 ± 7.4* 24.5 ± 6.1*
Zinc (mg)
Low 9.45 ± 5.72 6.41 ± 3.44 6.75 ± 3.00 <0.001
Medium 9.58 ± 5.87 13.0 ± 4.3* 12.9 ± 3.5*
High 7.77 ± 3.36 19.0 ± 5.7* 19.9 ± 6.2*
* = p < 0.05 compared to the low fortification group.
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percentage contribution of the fortified cereal to total
nutrient intake. The cereal supplement represented 13.4
± 6.6, 15.3 ± 4.3, and 12.7 ± 2.9% of total energy intake
during the study period for low, medium, and high
groups, respectively, and contributed ~20% to 85% of
the nutrients listed.
The mean total number of days with URTI during the
study period did not differ significantly between groups,
and subjects averaged 8.8 ± 10.9, 10.4 ± 6.5, and 7.4 ±
7.2 days with URTI for low, medium, and high groups,
respectively (p = 0.556). The percentage of children
reporting at least one URTI episode during the study
period did not differ between groups: 83%, 90%, and
74% for low, medium, and high groups, respectively (c
2
= 1.78, P = 0.411).
The pattern of change in leukocyte subset counts did
not vary significantly between groups (data not shown).
Pre- to post-study changes in natural killer cell function
(Table 3), granulocyte phagocytosis and oxidative burst
activity (Table 4), salivary IgA concentration and
s e c r e t i o nr a t e( T a b l e5 ) ,t h eg l o b a lI g Gr e s p o n s et o
pneumococcal vaccination (Figure 2), and DTH
response (Table 6) did not differ significantly between
groups.
Discussion
Despite significant improvements in dietary intake of
immune-related nutrients through ingestion of a forti-
fied cereal (~60 g/day) during a 2-month winter period,
URTI rates and pre- to- post-study changes in all
immune function measures did not differ between
groups. These data do not support the use of micronu-
trient fortified breakfast cereals by healthy, growing chil-
dren for the purpose of augmenting innate or adaptive
immune function and lowering URTI risk.
Although dietary nutrients are important for immuno-
competence in all humans [1], related benefits from
micronutrient supplements are most often reported in
populations with immune dysreglation such as malnour-
ished children, the frail elderly, diseased individuals, and
surgical or trauma patients [5-13]. Among healthy
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Figure 1 The percentage contribution of the fortified cereal to total nutrient intake after one and two months supplementation.
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Page 6 of 9adults, immune function remains robust over a wide
range of diet quality and nutrient intake, and adding
supplemental nutrients beyond what is obtained in the
traditional food supply has little if any discernable influ-
ence on immunity and infection rates [14-22]. In a dou-
ble-blinded, randomized, placebo-controlled study of
138 healthy adults aged 40-80 years, Wolvers et al. [21]
reported no effect of 10-weeks supplementation with a
micronutrient mix (vitamins E and C, b-carotene, and
zinc) on a range of immunological measures including
the antibody response to vaccination, phagocytosis and
oxidative burst activity, and lymphocyte proliferation.
An enhanced DTH response was reported, but this ben-
efit was limited to the older subjects, similar to data pre-
viously reported by Bogden et al. [37]. Other studies of
healthy adults with uncompromised immune systems
using single-nutrient supplements such as zinc, sele-
nium, or vitamin E have also reported negligible
immune benefits, although tocotrienol supplementation
may improve the immune response to a vaccine chal-
lenge [19-24,38].
To our knowledge, our study is the first to investigate
the influence of micronutrient supplementation through
breakfast cereal fortification on immune function and
URTI in healthy, school-aged youth. Kutukculer et al.
[32] studied the effect of acute, large dose vitamin A
and E supplementation on the IgG response to tetanus
toxoid immunization in healthy infants, and reported no
supplementation effect on the antibody response. Several
other studies have reported positive immunological
responses and reductions in acute lower respiratory
Table 3 Natural killer cell counts and activity (NKCA)
before and after two-months of cereal ingestion
(mean ± SD)*
Variable Pre-study Post-study Treatment interaction
p-value
NK lymphocytes (10
9/L) 0.578
Low 0.39 ± 0.28 0.23 ± 0.13
Medium 0.49 ± 0.34 0.36 ± 0.20
High 0.35 ± 0.18 0.29 ± 0.14
NKCA 40:1 E:T (% lysis) 0.448
Low 44.7 ± 16.8 48.8 ± 16.2
Medium 47.6 ± 14.1 47.1 ± 16.8
High 48.4 ± 16.3 48.6 ± 16.3
NKCA 20:1 E:T (% lysis) 0.349
Low 33.2 ± 16.3 37.0 ± 16.8
Medium 33.6 ± 12.7 35.5 ± 12.7
High 38.1 ± 17.1 36.3 ± 13.2
* Low (N = 24), medium (N = 21), high (N = 18) level of nutrient fortification
of the cereal product. Mean ±SD. E:T = effector-to-target ratio.
Table 4 Granulocyte phagocytosis and oxidative burst
activity before and after two-months of cereal ingestion
(mean ± SD)*
Variable Mean
flourescence
channel
Pre-study Post-study Treatment
interaction
p-value
Oxidative burst activity (DCF
+ Granulocytes) 0.184
Low 192 ± 65 136 ± 58
Medium 184 ± 79 171 ± 119
High 213 ± 77 141 ± 66
Phagocytosis (FITC
+ Granulocytes) 0.564
Low 459 ± 92 424 ± 84
Medium 426 ± 109 447 ± 170
High 442 ± 108 431 ± 93
* Low (N = 23), medium (N = 20), high (N = 19) = level of nutrient
fortification of the cereal product. DCF = dichlorofluorescein; FITC =
fluorescein isothiocyanate.
Table 5 Salivary IgA concentration and secretion rate
before and after two-months of cereal ingestion (mean
±SD)*
Variable Pre-study Post-study Treatment
interaction
p-value
Saliva IgA concentration (μg
. mL
-1) 0.461
Low 333 ± 181 314 ± 152
Medium 292 ± 143 302 ± 151
High 315 ± 159 289 ± 158
Saliva protein IgA concentration (μg
. mg
-1) 0.675
Low 471 ± 162 484 ± 156
Medium 444 ± 170 419 ± 155
High 535 ± 224 499 ± 187
Saliva IgA secretion rate (μg
. min
-1) 0.476
Low 173 ± 135 220 ± 163
Medium 185 ± 118 233 ± 129
High 207 ± 118 212 ± 74
* Low (N = 21), medium (N = 24), high (N = 19) = level of nutrient
fortification of the cereal product.
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Figure 2 The 4-week global IgG response to pneumococcal
vaccination did not differ between supplementation groups
(interaction effect, p = 0.7862).
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Page 7 of 9infection and diarrhea to nutrient supplementation in
malnourished or infected young children [25-31]. Thus
the limited data available on the relationship between
micronutrient intake and supplementation on immune
function in children is consistent with data collected in
adult populations: supplemental micronutrients are effi-
cacious among those suffering from syndromes related
to immune dysfunction but unlikely to augment
immune function or decrease infection risk among well
nourished and healthy individuals.
Among our “medium” and “high” supplement groups,
ingestion of the fortified breakfast cereal represented
~20-85% of total dietary intake for zinc, iron, vitamin
B6, folate (and other B complex vitamins), and antioxi-
dant vitamins. Supplemental capsules containing a
micronutrient mixture would have provided a greater
quantity, but this study was designed to test the utility
and efficacy of using a fortified breakfast cereal delivery
system. The volume of breakfast cereal consumed per
day by our young subjects (mean of ~60 g or 2.7 cups)
over a two month period approached the maximum
amount they could tolerate. For the five key immune-
related nutrients in the “high” fortification group–vita-
mins A, C, and E, zinc, iron–supplementation with the
fortified cereal product by the children during the study
provided approximately 30% of the U.S. Daily Value
above typical food intake. Thus at the nutrient density
used in this study, the strategy of using fortified break-
fast cereal to improve immune function and lower URTI
risk in healthy children is not recommended.
Conclusions
In conclusion, our hypothesis of URTI incidence reduc-
tion and immune modulation in healthy, school-aged
children through ingestion of a breakfast cereal fortified
with immune-related nutrients was not supported. We
measured URTI rates and conducted a variety of in vitro
and in vivo measures of both innate and adaptive
immune function, and failed to find any significant
group differences during a 2-month winter period. Thus
within the context of this investigation, our data do not
support the use of immune benefit claims for healthy,
s c h o o l - a g e dc h i l d r e nf r o mi n g e s t i o no ff o r t i f i e db r e a k -
fast cereal.
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